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Prevalence of cytomegalovirus IgG antibodies, potential risk factors and awareness 
of congenital cytomegalovirus among female doctors 
 
Abstract 
   Female staff in children-Mother care hospitals may run an increased risk of 
cytomegalovirus (CMV) contact infection leading to a congenital CMV feto-pathy 
during pregnancy. Also, because of limited treatment options for congenital 
cytomegalovirus infection, preventive strategies are important so knowledge and 
awareness among doctors are essential for the success of preventive strategies. 
Thus this study was carried out to determine the positive rate of IgG among female 
doctors at age bearing who care for children and mothers in Sana'a hospitals. Also, to 
investigate the knowledge of congenital CMV among doctors involved in the study. 
   This cross sectional study was carried out for one year (June 2017- June 2018); 
Ninety one Yemeni females were included in this study. 23 (12.9%) of the total 
female doctors were pediatrics, 32(18%) gynecology and obstetrics, 9 (5.1%) Oto-
rhinolaryngology and 114 (64%) were general practices. 
   Blood samples were collected from all participants and tested for IgG antibodies of 
HCMV by ELISA. The individual's data were collected in a pre-designed 
questionnaire including; demographic data, risk factors. Also, a questionnaire on 
CMV infection was answered by doctors on the knowledge concerning epidemiology, 
transmission, symptoms and signs of CMV infection in adults and children; and 
treatment options. 
    13.4% of female doctors were negative (HCMV IgG <9 SU), while the rest 
(86.6%) were positive (HCMV IgG ≥ 11 SU). There was escalate trend of positive 
HCMV IgG antibodies rate with increasing age, significance association between 
sero-positive HCMV IgG antibodies and parity (OR=3.1, p=0.01), 1-3 pregnancy rate 
(OR=2.2, p=0.05), and history of surgery (OR=3.8, p=0.01). Most of the doctors were 
aware that most healthy adults and pregnant women do not experience any symptoms 
of a CMV infection (66.8%); and only one-fifth of the respondents were aware that 
kissing, and changing diapers, are risk factors for the transmission of CMV. Also, 
only half of the total respondents were aware that microcephaly (59%), and hearing 
loss (56.7%) could be symptoms of congenital CMV. 
   This study revealed that the HCMV is highly endemic in our population where the 
prevalence of IgG among the medical female doctors was 86.5%, thus HCMV should 
be considered as a possible cause of morbidity and mortality in fetus and might in 
mothers in Yemen. Increasing knowledge and awareness is expected to enhance the 
prevention of transmission, to improve recognition, and to stimulate diagnostic 
investigations and follow-up programs. 
Keywords: CMV, staff in children-Mother care hospitals, risk factors, knowledge, 
awareness. 
Introduction  
Human cytomegalovirus  is a member of the Herpesviridae family, and the virus may 
be shed intermittently in bodily fluids (saliva, urine, semen, blood and breast milk). 
As such, its transmission occurs both horizontally and vertically through close contact 
and directly from mother to embryo, fetus, or baby. Upon primary infection, which is 
usually asymptomatic, HCMV establishes a state of lifelong latency, during which 
infectious virus is difficult to isolate. Active HCMV infection can result from primary 
infection in a previously sero-negative individual or reactivation in a sero-positive 
  
individual 
1, 2 
in response to immune-suppression and inflammation. Viral reactivation 
is associated with significant morbidity and mortality in immune-compromised 
individuals, such as patients with HIV infection or those undergoing solid organ or 
bone marrow transplantation, and up to 15 % of babies who acquire congenital 
infection, manifest signs of cytomegalic inclusion disease (CID) at birth.
3, 4
 
Seroprevalence of HCMV varies from 30 to 90 % in most developed countries and the 
seroprevalence is dependent on sociodemographic factors. Adult populations in 
Africa, Asia and South America 
5
 have higher HCMV seroprevalence than European 
6, 7
 and North American populations. Vaccines are being developed for CMV.
8
   To 
inform potential vaccination programmes, it is essential to understand the current 
epidemiology of this infection in childhood. Maternal sero-prevalence has a 
significant impact on the pediatric epidemiology of these infections, while children 
frequently transmit herpes viruses to their mothers.
9,10
  Congenital CMV infection is 
the most common congenital infection worldwide, and in the developed world it is the 
leading non-genetic cause of sensorineural hearing loss (SNHL) in children and an 
important cause of neuro-developmental delay.
2
 While awaiting treatment options, the 
burden of disease can be decreased by preventive strategies that reduce the risk of 
transmission of CMV to the pregnant woman.
11
 A recent review of the 
implementation of educational hygiene interventions provides preliminary support for 
the positive effect of preventive strategies.
12
  The success of preventive strategies 
depends on the active involvement of the doctors involved in mother and child care. 
Awareness of the epidemiology, transmission, diagnosis and prevention of congenital 
CMV is essential for every doctor. Studies report on the knowledge of women of 
childbearing age, and obstetricians, concerning congenital CMV.
13 
At the current 
time, there is minimal information regarding the epidemiological determinants of 
HCMV infection in Yemen. We undertook a study to determine the prevalence of 
CMV antibodies level as marker for immunological status for CMV in female doctors 
(risk group for congenital cytomegalovirus). Also to determine general potential risk 
factors of contracting CMV and occupational risk factors among this group. In 
addition to investigate the knowledge of transmission  routes of  CMV, clinical 
manifestation and congenital sequle of CMV among doctors involved in mother and 
child care in Sana'a city. 
Subjects and Methods  
In the present study, a total number of 178 female doctors of hospitals in Sana'a city 
were enrolled.  63 (35.4%) of the total doctors were working in Al-Sabian University 
hospital, 16 (9%) were working in The Mother hospital, 12(6.7%) working in SMSH 
(YFCA), 58 (32.6%) working in Al-Thorah University Hospital and 29 (16.3%) 
working in Al-Kuwait University Hospital. The individual's data were collected in a 
pre-designed questionnaire including; demographic data, risk factors. Also, a 
questionnaire on CMV infection was answered by doctors on the knowledge 
concerning epidemiology, transmission, symptoms and signs of CMV infection in 
adults and children, and treatment options were evaluated. Serum samples of female 
doctors were tested for HCMV IgG antibodies using standard, validated and 
commercially available enzyme-linked immunosorbent assay (ELISA) (Abcam’s).  
Statistical analysis 
To relate possible risk factors for CMV infection, the data were examined in a case-
control study format. For HCMV, persons with evidence of previous or current 
infection with HCMV (HCMV IgG antibodies-positive) were matched up with those 
who were HCMV IgG antibodies negative. Differences in categorical variables were 
assessed using Fisher's exact tests where appropriate. Ninety-five percent confidence 
  
intervals for odds ratios were calculated according to the method of Cornfield and 
95% confidence limits for simple proportions were calculated by an exact binomial 
method using EPI-INFO. 
Results: 
In the present study, a total number of 178 female doctors of hospitals in Sana'a city 
were enrolled.  The detailed results of this study are presented in tables 1, 2,3,4,5 and 
6.  13.4% of female doctors were negative (HCMV IgG <9 SU), while the rest 
(86.6%) were positive (HCMV IgG ≥ 11 SU), 51.7% of them had high amount of 
HCMV IgG. There was escalate trend of positive HCMV IgG antibodies rate with 
increasing age, significance association between sero-positive HCMV IgG antibodies 
and parity (OR=3.1, p=0.01), 1-3 pregnancy rate (OR=2.2, p=0.05), and history of 
surgery (OR=3.8, p=0.01).  Table 5 and 6 shows the  number and percentage of stated 
Yes responses per multiple choice items on the CMV Questionnaire for all female 
doctors participate in the study to test knowledge concerning of HCMV clinical signs 
in adults, route of  transmission and  postnatal symptoms of HCMV. Most of the 
doctors were aware that most healthy adults and pregnant women do not experience 
any symptoms of a CMV infection (66.8%); and only one-fifth of the respondents 
were aware that kissing, and changing diapers, are risk factors for the transmission of 
CMV. Also, only half of the total respondents were aware that microcephaly (59%), 
and hearing loss (56.7%) could be symptoms of congenital CMV.  
Discussion 
  Staff in hospitals may run an increased risk of cytomegalovirus (CMV) contact 
infection leading to a congenital CMV feto-pathy during pregnancy. The main risk 
factor is close contact with unapparent carriers of CMV among infants etc. We 
therefore examined CMV seroprevalence and possible risk factors for CMV infection 
among staff at a Mother-children’s hospitals. To our knowledge, this is the first 
documented data in Sana'a city regarding the epidemiology of and knowledge of 
HCMV among Yemeni female doctors. According to the current study high 
percentage of Anti-HCMV IgG antibodies (86.5%) among participating doctors 
indicated  either past infection (apparently sub-clinical), current active sub-clinical 
disease or exposure to virus without active disease. After HCMV exposure or 
infection, IgG remains for the rest of life as protective antibody against the next 
infection. However, the primary HCMV infection needs to be elucidated either as 
recurrent or new infection by specific HCMV IgG avidity test.  
This sero-prevalence of HCMV IgG antibody in our study (86.5%) was slightly 
higher than what reported in China (81.7%) 
14
 and much higher than reported in 
developed countries as France (51.1%) 
15
 and UK (51.5%)
16
  among female doctors 
but lower to countries like Thailand, where figures of 100% sero-prevalence 
reported.
17 
Also, when we compared our finding with pregnant women in previous 
Yemeni and Arab studies , our finding was lower than Sana’a city (100%) 18 ;  
Hodeida city (98.7%)
19
  , Taiz city (99%) 
20
 Iraq (100%) 
21
 Egypt (100%) 
22
 and 
Sudan (97.5%) 
23
,  and also lower than that of  Iran (98.8%) 
24
, and Nigeria (94.8%)
25
. 
These high rates may be due to the poor hygienic practices and low socioeconomic 
status that might play significant roles in increasing the rate of HCMV exposure and 
infection.
 
  Despite the general very high seroprevalence of HCMV infection, 13.5 % of 
female's population remained seronegative. It is likely that good hygiene, hand 
washing and limited sharing of edibles and used utensils serve to limit infection rates 
in some populations.
26
 Also, the low HCMV-IgG negative profile (13.5 %) indicates 
that the great majority of infections occur during childhood although our data also 
  
reveal a significant increase in seroprevalence of the female doctor's age group ≥ 
35years. 
 In our study 51.7% of female doctors showed high titer production of HCMV IgG 
antibodies. IgG high titer production is likely to indicate a response to endogenous 
viral reactivation and suggests that the more frequent exposure to viral infection 
within the hospitals may boost protective endogenous immunity. 
    In this study, the age was essentially connected with CMV infection, there was 
escalate trend of positive HCMV IgG antibodies rate with increasing age in which the 
highest rate of positive HCMV IgG antibodies was in the oldest age group ≥35 years 
in which the positive rate was 96.2%, with associated OR equal to 4.6., and this result 
could be explained to debilitating of the immune system with increment in age and 
longer time of exposure to the virus on older people. The association between 
increasing age and HCMV IgG sero-prevalence positive in our study is similar to that 
reported elsewhere, were sero-positivity of HCMV increases steadily throughout 
adulthood.
27
 
The highest rate of positive HCMV IgG antibodies was in gynecology and 
obstetrics doctors in whom the rate was 93.8% with associated OR equal to 2.7, 
followed by the rate in pediatrics in which the rate was 91.3% with associated OR 
equal to 1.7. In oto-rhinolaryngology doctors the rate of positive HCMV IgG 
antibodies was 88.9%. In general practice doctors the  positive HCMV IgG antibodies 
rate was 83.3% (the lowest) (table 3), but the variations between these rates were 
statistically non-significant related to the risk of HCMV positivity, since they did not 
reach significant levels. This result is different from previous reports in which 
pediatrics were the most risk doctors  because close contact with children below the 
age of three is considered to be the most important risk factor. Children can be 
unapparent CMV carriers. Over several months or years, they secrete large quantities 
of CMV in urine and saliva after having themselves been infected prenatally via the 
placenta or postnatal via breast milk or contact with other carriers, usually children. 
That is why, in line with current government recommendations, a ban on employment 
in paediatric medicine, depending on the specific area of work and activities, has to be 
examined particularly for female doctors at age bearing ime.
28
  
   This study showed a significance association between sero-positive HCMV IgG 
antibodies and parity (motherhood) in which the sero-positive HCMV IgG antibodies 
rate was 92.2%, with associated OR equal to 3.1, CI=1.3-7.7, with significant  χ 2=6.5 
and p=0.01(table 4).  Parity was observed before as risk factors for increased 
susceptibility to acquiring CMV infection, perhaps through the direct contact with 
contagious secretions from their own children and poor hygiene practiced by these 
women
 29, 30
, so an effective prevention approach should take into account in all cases 
particularity in high parity families. The direct contact with infectious secretions from 
children of the pregnant women in addition to poor hygiene practiced by those women 
may increase the HCMV exposure leading to infection at any stage of pregnancy 
29, 30
, 
but the above situation was in disagreement to other published studies. 
31, 32
  
    There was significance association between sero-positive HCMV IgG antibodies 
and history of surgery in which the sero-positive HCMV IgG antibodies rate was 
94.4%, with associated OR equal to 3.8, CI=1.3-11.7, with significant  χ 2=6.2 and 
p=0.01. Most surgery accompanied with blood transfusion infection which may lead 
to significant obstacles in immune-compromised persons. This is similar to study that 
carried out in Kenya.
21
 However, in dissimilarity to other studies in Mexico and 
Nigeria.
33, 34
 
  
   In the this study the following variants like history of miscarriage, infection, blood 
transfusion and cupping were not related to the risk of HCMV positivity, since they 
did not reach significant levels. However, some authors reported a significant 
association between history of miscarriage and blood transfusion with HCMV IgG 
seropositivity.
35, 36
 
   We investigated the knowledge of congenital CMV infection among female doctors 
in Sana'a city involved in mother and child care. Several interesting findings were 
shown. First, doctors seemed to miscalculate the chance of encountering a child with 
congenital CMV infection in medical practice. There seemed to be a risk of under 
diagnosis, since the prevalence of congenital CMV, internationally do not estimated 
sometimes overestimated, but more frequently underestimated by respondents in this 
study (only 21% answer yes for possible occurring congenital HCMV in Yemen). 
Secondly, preventive strategies are assumed to be effective only when doctors are 
sufficiently well informed to advise their patients properly. The data in this study 
show that most of the doctors were aware that most healthy adults and pregnant 
women do not experience any symptoms of a CMV infection (66.8%). Worryingly, 
however, only one-fifth of the respondents, including those working with pregnant 
patients, were aware that kissing, and changing diapers, are risk factors for the 
transmission of CMV.  
   Thirdly, including congenital CMV infection in the differential diagnosis in 
symptomatic newborns is crucially important. Since only half of the total respondents 
in this study were aware that microcephaly (59%) and hearing loss (56.7%) could be 
symptoms of congenital CMV, it seems possible that these children may be left 
undiagnosed, with possibilities for treatment and follow-up not explored. It is 
worrying that only 20.2% of all respondents realized that congenital CMV frequently 
does not give rise to any symptoms and signs at birth, and that 14% of these 
asymptomatic newborns will develop long-term sequelae.
37
 Finally, we were 
surprised that 45% of the respondents thought that the antiviral therapy of newborns 
with congenital CMV infections is common practice in the world. Even though 
antiviral therapy has been shown to prevent hearing deterioration in newborns with 
symptomatic CMV infections, this practice is not yet widespread worldwide. 
38
 
In the case of CMV it is especially important that doctors involved in the care of 
women who are or who may become pregnant are able to advice on the risk of 
congenital CMV and how this risk may be reduced. To date, information on 
congenital CMV is not regularly included in preconception and antenatal 
consultations.  
Conclusion: This study revealed that the HCMV is highly endemic in our population 
where the prevalence of IgG among the medical female doctors in age bearing was 
86.5%, thus HCMV should be considered as a possible cause of morbidity and 
mortality in fetus and might in mothers in Yemen. Increasing knowledge and 
awareness is expected to enhance the prevention of transmission, to improve 
recognition, and to stimulate diagnostic investigations and follow-up programs. 
Recommendation: Control measures should be applied in hospitals as well as routine 
investigation for HCMV in pregnant women. Also vaccine, prophylactic and pre-
emptive strategies should be developed. 
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Table 1: The levels of HCMV IgG antibodies among female doctors in Sana'a city, 
Yemen, 2018. 
 
Level titers (Standard Units) 
The levels of  HCMV IgG antibodies 
Number % 
Negative (<9 SU) 24 13.5 
Low positive (11-26 SU) 11 6.2 
Medium positive (27-42 SU)  51 28.6 
High positive (> 42 SU)  92 51.7 
Total 178 100 
SU=Standard Units  
Cut-off: 10 SU 
Grey zone: 9-11 SUs= repeated 
Negative: <9 SU 
Positive: >11 SU  
Table 2: The seroprevalence of HCMV IgG antibodies in relation with age of female's 
participants. 
 
Age groups 
HCMV IgG 
positive (n = 
154) 
OR CI   χ 2     p 
No. % 
≤30 years n=29 21 72.4 0.31 0.1-0.8 5.9 0.01 
31-34 years n=123 108 87.8 1.4 0.6-3.4 0.56 0.45 
≥35 years n=26 25 96.2 4.6 0.8-34 2.4 0.11 
Total n=178 154 86.5  
 
OR          Odds ratio = Relative risk  
CI           Confidence intervals  
 Χ 2          Chi-square = 3.9 or more significant 
 PV           Probability value = 0.05 or less is significant 
 
  
Table 3: The seroprevalence of HCMV IgG antibodies in relation with specialty of 
work for female doctors. 
 
Field of works 
 
HCMV IgG 
positive (n = 
154) 
OR CI   χ 2     p 
No. % 
Pediatrics n=23 21 91.3 1.7 0.3-7.9 0.5 0.47 
Gynecology and 
obstetrics n=32 
30 93.8 2.7 0.6-11.9 1.8 0.18 
Oto-rhinolaryngology 
n=9 
8 88.9 1.2 0.1-10 0.045 0.8 
General practice n=114 95 83.3 0.4 0.1-1.1 2.8 0.09 
Total n=178 154 86.5  
 
OR          Odds ratio = Relative risk  
CI           Confidence intervals  
 Χ 2          Chi-square = 3.9 or more significant 
 pv           Probability value = 0.05 or less significant 
 
Table 4: The association between sero-positive HCMV IgG antibodies with host 
factors of female doctor participants. 
 
Factors 
HCMV IgG 
positive (n = 
154) 
OR CI   χ 2     p 
No. % 
 Motherhood (parity)  
Yes n= 102 
94 92.2 3.1 1.3-7.7 6.5 0.01 
No n= 76                  60 78.9 0.3 0.12-0.7 6.5 0.01 
Number of pregnancy ended with live child 
1-3 n= 89 81 91 2.2 1-5.5 3.9 0.05 
<3 n=13 
 
13 100 undefined 2.1 0.13 
Spontaneous Abortion 
history of miscarriage 
 n=19 
 
18 94.7 3 0.4-23 1.2 0.26 
1-3 n= 16 
 
14 87.5 1.1 0.23-5.1 0.041 0.9 
<3 n= 3 2 66.6 0.3 0.02-3.5 1.03 0.3 
History of infection diseases 
n= 35 
29 82.8 0.69 0.25-1.9 0.5 0.47 
Blood transfusion n=19 17 89.5 1.3 0.3-6.3 0.15 0.67 
Cupping n= 4 3 75 0.45 0.04-4.5 0.46 0.49 
Surgery n= 71 67 94.4 3.8 1.3-11.7 6.2 0.01 
 
OR          Odds ratio = Relative risk CI           Confidence intervals  χ 2          Chi-square = 3.9  or more significant 
pv           Probability value = 0.05 or less  significant 
 
  
Table 5: The number and percentage of stated Yes responses per multiple choice 
items on the CMV Questionnaire for all female doctors participate in the study to test 
knowledge concerning of HCMV 
Knowledge concerning Number percentage 
Is HCMV problem in Yemen (Yes) 37 21 
Transmission route 
True answers 
Kissing 
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43.8 
Changing diapers 39 21.9 
Breast milk:  53 29.8 
Blood contact:  82 46.1 
Sexual intercourse:  38 21.3 
False answers  
Air conduction:  
101 56.7 
Direct skin contact:  39 21.9 
Symptoms in immune competent adults 
True answers 
 
  
No symptoms    119 66.8 
Not feeling well    59 33.2 
Fever 59 33.2 
Elevated liver enzymes    37 20.6 
False answers 
Cardiac problems  
9 5.1 
Thrombosis 7 3.9 
Visual problems    22 12.4 
Table 6: The number and percentage of stated Yes responses per multiple choice 
items on the CMV Questionnaire Postnatal symptoms for female doctors in Sana'a 
city hospitals 
Knowledge concerning Number percentage 
Postnatal symptoms  
 True answers 
No symptoms  36 20.2 
Petechiae    91 51.1 
Microcephaly  105 59 
Seizures 28 15.7 
False answers 
Heart defect  59 33.1 
Macrosomia 5 2.8 
Renal problems  28 15.7 
Anal atresia    3 1.7 
Long-term effects  
True answers 
Hearing loss    101 56.7 
Cognitive delay  85 47.8 
Motor delay   51 28.6 
Seizures  23 12.9 
Autism    2 1.1 
Visual problems  58 32.6 
False answers   
Obesity  3 1.7 
Increased risk for malignancy  26 14.6 
viable and use of Antiviral therapy worldwide 
(Yes) 
80 45 
 
